During the opening lecture at the International Conference on Advanced Technologies & Treatments for Diabetes, Melanie Davies, CBE, MB, ChB, MD, FRCP, FRCGP, professor of diabetes medicine at the University of Leicester and an honorary consultant diabetologist at the University Hospitals of Leicester NHS Trust, reviewed how GLP-1 receptor agonists such as semaglutide (Ozempic/Wegovy, Novo Nordisk) have changed the way providers approach the treatment of type 2 diabetes and obesity and discussed some of the medications that combine GLP-1 with other molecules
Cellular debris were separated and discarded through centrifugation at 14,000 rpm for 10 min at 4 C
While both patient groups see major improvements in blood sugar control, women adding HRT to their regimen achieve sharper drops in blood pressure, harmful blood fats (triglycerides), and liver inflammation
Lipid nanoparticles as the drug carrier for targeted therapy of hepatic disorders
But do not expect these results to come right away, rather think of it as something that comes after a few weeks of consistent use
Zhan YT, Su HY, An W